ACTalks Blogs

 View Only

STP Short Education Webinar Series—Cardiovascular Safety Assessment

By Jordan Ehler posted 08-20-2018 01:13 PM

  

Short Webinar Series
Cardiovascular Safety Assessment 

The Society of Toxicologic Pathology (STP) Internet Committee-Web-based Education Subcommittee (WBEC) is pleased to offer these quarterly Short Education Webinar Series as an educational tool to foster collaboration among the toxicologic pathology community. The third of the series, Cardiovascular Safety Assessment, features six presentations from a half-day Continuing Education Course at the STP Annual Symposium held in Boston, Massachusetts (June 2012).

These presentations will explore current understandings of mechanisms of toxicity in the cardiovascular system and put that understanding in the context of how we do our nonclinical assessments. An introductory overview will bring the audience to a common level of understanding around cardiovascular form and function, potential cellular and molecular targets of toxicity, and bridge into the compromised target patient population. Subsequent sessions will explore contemporary and mechanistically diverse areas of toxicity. Individual presentations will review our current level of understanding with respect to mechanisms of toxicity, review how current assessment paradigms address (or not) these mechanisms, and offer biomarker recommendations. 

INTRODUCTION TO THE CARDIOVASCULAR SYSTEM AS A TARGET OF DRUG-INDUCED TOXICITY
Michael Boyle, DVM, DACVP, Amgen, Thousand Oaks, CA

CARDIOVASCULAR TOXICITY OF ONCOLOGY DRUG
Thomas Force, MD, Center for Translational Medicine, Temple University School of Medicine

STRUCTURAL CARDIOVASCULAR INJURY AND HEMODYNAMICALLY-ACTIVE DRUGS: THE STRUCTURE-FUNCTION INTERFACE
Heath C. Thomas, DVM, PhD, DACVP, GlaxoSmithKline

DRUG-INDUCED MITOCHONDRIAL DYSFUNCTION AND CARDIOTOXICITY
Ingrid Pruimboom-Brees, DVM, PhD, DACVP, Novartis Pharma AG

CARDIOMYOCYTE CALCIUM HANDLING AND CARDIOTOXICITY
Michael Quaile, PhD, GlaxoSmithKline, Laboratory Animal Sciences

BIOMARKERS OF CARDIOTOXICITY-CHALLENGES FOR PRESENT AND FUTURE
Eric Schultze, DVM, PhD, DACVP, FIATP, Lilly Research Laboratories

           
   

Not a member? Apply today to receive all STP member benefits.

   

Subscribe to receive updates on new content.

           
Society of Toxicologic Pathology | 11190 Sunrise Valley Drive, Suite 300 | Reston, VA 20191
(703) 438-7508 | Fax: (703) 438-3113 | STP Headquarters


Copyright © *2018 Society of Toxicologic Pathology, All rights reserved.


You may view the Privacy Policy or opt in/out of email communications from STP at any time.
0 comments
0 views